CK19 Combined With Contrast-enhanced Ultrasound: a Prediction System on Axillary Lymph Node Metastasis in Breast Cancer

NCT02992067 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 359

Last updated 2019-10-04

Study results available
· View outcomes & findings →

Summary

To establish a predicting system on axillary lymph node metastasis based on peripheral blood CK19mRNA and contrast-enhanced ultrasound.

Conditions

  • Lymph Node
  • Breastcancer

Sponsors & Collaborators

  • Second Affiliated Hospital, School of Medicine, Zhejiang University

    collaborator OTHER
  • Zhejiang Cancer Hospital

    lead OTHER

Principal Investigators

  • Xingfei Yu, M.D. · Zhejiang Cancer Hospital

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-04-30
Primary Completion
2017-04-30
Completion
2017-07-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02992067 on ClinicalTrials.gov